BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19763024)

  • 21. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta.
    Andriambeloson E; Kleschyov AL; Muller B; Beretz A; Stoclet JC; Andriantsitohaina R
    Br J Pharmacol; 1997 Mar; 120(6):1053-8. PubMed ID: 9134217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-dependent and -independent vasorelaxation induced by CIJ-3-2F, a novel benzyl-furoquinoline with antiarrhythmic action, in rat aorta.
    Chang GJ; Lin TP; Ko YS; Lin MS
    Life Sci; 2010 Jun; 86(23-24):869-79. PubMed ID: 20388521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoflurane does not vasodilate rat thoracic aortic rings by endothelium-derived relaxing factor or other cyclic GMP-mediated mechanisms.
    Brendel JK; Johns RA
    Anesthesiology; 1992 Jul; 77(1):126-31. PubMed ID: 1319121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of nitric oxide and K+ channel activation to vasorelaxation of isolated rat aorta induced by procaine.
    Huang Y; Lau CW; Chan FL; Yao XQ
    Eur J Pharmacol; 1999 Feb; 367(2-3):231-7. PubMed ID: 10078997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat.
    Hayakawa H; Hirata Y; Kakoki M; Suzuki Y; Nishimatsu H; Nagata D; Suzuki E; Kikuchi K; Nagano T; Kangawa K; Matsuo H; Sugimoto T; Omata M
    Hypertension; 1999 Feb; 33(2):689-93. PubMed ID: 10024329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators.
    Anwar MM; Meki AR; Rahma HH
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Nov; 130(3):357-67. PubMed ID: 11701392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of interferon-alpha in reducing the endothelium-dependent relaxation of rat thoracic aorta].
    Yao H; Cao CM; Jin HF; Shan QX; Wang LL; Xia Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):202-6. PubMed ID: 12881863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta.
    Topouzis S; Schott C; Stoclet JC
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):670-8. PubMed ID: 1723763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasorelaxant effects of Cerebralcare GranuleĀ® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
    Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
    J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
    Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
    Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
    Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
    J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling.
    Chitaley K; Webb RC
    Hypertension; 2002 Feb; 39(2 Pt 2):438-42. PubMed ID: 11882586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells.
    Wang GJ; Wu XC; Chen CF; Lin LC; Huang YT; Shan J; Pang PK
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1237-44. PubMed ID: 10336511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in protein kinase G-mediated vasorelaxation of rat aorta.
    Teede H; van der Zypp A; Majewski H
    Clin Sci (Lond); 2001 May; 100(5):473-9. PubMed ID: 11294687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 beta rapidly inhibits aortic endothelium-dependent relaxation by a DNA transcription-dependent mechanism.
    Loughrey JP; Laffey JG; Moore BJ; Lynch F; Boylan JF; McLoughlin P
    Crit Care Med; 2003 Mar; 31(3):910-5. PubMed ID: 12627004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
    Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1beta-induced, nitric oxide-dependent and -independent inhibition of vascular smooth muscle contraction.
    Takizawa S; Ozaki H; Karaki H
    Eur J Pharmacol; 1997 Jul; 330(2-3):143-50. PubMed ID: 9253947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.